Skip to content
Search

Latest Stories

Study reveals flawed research on moderate alcohol health benefits

New findings challenge the long-held belief that moderate drinking is good for health

Study reveals flawed research on moderate alcohol health benefits

STUDIES suggesting that moderate alcohol consumption enhances longevity and lowers the risk of heart problems and chronic diseases compared to abstaining are based on "flawed scientific research," a new study has found.

Published over the years, these studies have led to a widespread belief that alcohol can be healthy if taken in moderation, ranging from a drink a week to two per day.


Researchers found that these studies have largely focused on moderate drinking among older adults, comparing them with 'abstainers' and 'occasional drinkers' — both groups were found to include older adults who had quit or reduced drinking due to health conditions.

"That makes people who continue to drink look much healthier by comparison," said lead researcher Tim Stockwell, a scientist with the Canadian Institute for Substance Use Research, University of Victoria.

By failing to account for people's lifetime drinking habits, these studies "suffer from fundamental design flaws," according to the authors. The findings are published in the Journal of Studies on Alcohol and Drugs.

"There is simply no completely 'safe' level of drinking," Stockwell said.

The team identified 107 published studies examining the relationship between drinking habits and longevity.

Combining all the data, it appeared that light to moderate drinkers had a 14 percent lower risk of dying during the study period compared with those abstaining from alcohol, the researchers said.

However, upon closer examination, they found that in "higher quality" studies — which analyzed drinking habits of people on average younger than 55 and ensured that former and occasional drinkers were not counted as 'abstainers' — alcohol in moderation was not linked to a longer life.

"As predicted, studies with younger cohorts and separating former and occasional drinkers from abstainers estimated similar mortality risk between low-volume drinkers and abstainers," the authors wrote.

In contrast, "lower quality" studies, involving older adults and not differentiating between former drinkers and lifelong abstainers, were the ones that linked moderate drinking with greater longevity, the authors said.

"If you look at the weakest studies, that's where you see health benefits," Stockwell said.

Due to these biases in sample selection, the studies could create misleading links between drinking and health benefits, and "can confuse communications about health risks," the authors said.

The links between moderate alcohol consumption and health benefits were first published in 1926 in a book by American biologist Raymond Pearl, called 'Alcohol and Longevity.'

In recent years, multiple studies have found that there is no such thing as a 'safe level of alcohol consumption.'

In January 2023, the World Health Organization (WHO) published a statement in The Lancet Public Health journal: "When it comes to alcohol consumption, there is no safe amount that does not affect health."

(PTI)

More For You

‘UK, Take Notes’: British YouTuber Raves About Indian Train Meal

Many viewers were both amused and impressed by the efficiency of Indian railway food delivery

Instagram/ georgebxckley

British YouTuber’s train meal in India leaves him saying, 'UK, take notes'

A British content creator recently experienced a unique moment while travelling by train across India—receiving a food delivery directly to his seat. George Buckley, a travel and lifestyle influencer, captured the experience in a video, showing how a meal ordered through Zomato was delivered to him at Kanpur Central Station during a brief five-minute stop.

Buckley uploaded the video with a humorous caption: "The UK needs to take notes." In the clip, he documents the full process, from ordering to receiving the meal, and thanks a fellow Indian passenger who helped him. “It was great meeting you, my friend,” he wrote in appreciation.

Keep ReadingShow less
Capivasertib: New NHS Pill Slows Incurable Breast Cancer Progression

Around 3,000 women each year could benefit from the treatment

iStock

New pill Capivasertib slows incurable breast cancer progression, now on NHS

A new drug for one of the most common forms of advanced breast cancer, capivasertib, is now available on the NHS in England. Around 3,000 women each year could benefit from the treatment after clinical trials showed it can slow the progression of the disease and shrink tumours in a significant number of patients.

The National Institute for Health and Care Excellence (NICE) has approved capivasertib for NHS funding. It is one of a range of treatment options offered to patients whose breast cancer has spread and is no longer curable.

Keep ReadingShow less
Eric Dane

There is currently no cure for ALS

Getty

Grey’s Anatomy and Euphoria star Eric Dane diagnosed with ALS

Eric Dane, best known for his roles in Grey’s Anatomy and Euphoria, has revealed he has been diagnosed with amyotrophic lateral sclerosis (ALS).

ALS, also referred to as motor neurone disease (MND) in the UK, is an incurable condition that progressively damages nerve cells in the brain and spinal cord, leading to increasing muscle paralysis. The disease affects around 153,000 people in the UK, though awareness of its wider range of symptoms remains relatively low.

Keep ReadingShow less
Top 10 Early Warning Signs of Parkinson’s Disease You Need to Know

Parkinson’s can impact quality of life

iStock

10 early warning signs of Parkinson’s disease you should know

Parkinson’s disease is the world’s fastest-growing neurological condition, yet public understanding often stops at its well-known tremors.

Despite affecting 153,000 people in the UK, awareness around its wider range of symptoms remains limited, according to Parkinson’s UK. Even with famous figures like Billy Connolly, Michael J. Fox, Neil Diamond, Linda Ronstadt, and Ozzy Osbourne speaking openly about living with the disease, many early signs still go unrecognised.

Keep ReadingShow less